BioSpace News Archive

Eye Care Surgical Devices Market: Increase in Prevalence of Diseases Related to Eyes Are Driving the Market

Surgical devices are used in retinal, refractive, and cataract surgeries to treat diseases such as age related macular degeneration, diabetic eye disease, and glaucoma.

February 9, 2022

·

6 min read

Clostridium Difficile Infection Treatment Market: Drivers, Opportunities & Geographical Analysis

Clostridium difficile infection treatment market is characterized by the approvals of the new class of drugs.

February 9, 2022

·

5 min read

Rare Neurological Disease Treatment Market to Expand by 2.3X – Fact.MR Exclusive Report

The rare neurological disease treatment market study by Fact.MR offers compelling insights into key growth drivers and restraints impacting the market through 2028.

February 9, 2022

·

6 min read

Drug Development

Hummingbird Bioscience Publishes Preclinical Data Demonstrating Therapeutic Potential of HMBD-002 in VISTA-expressing Cancers

Hummingbird Bioscience announced the publication of preclinical data for HMBD-002, a novel anti-VISTA antibody therapeutic, in the Journal for ImmunoTherapy of Cancer, a peer-reviewed journal of the Society for Immunotherapy of Cancer.

February 9, 2022

·

3 min read

BioMidwest

Secura Bio Announces Final Patient Enrolled in the COPIKTRA® (duvelisib) (PRIMO) Study in Relapsed and Refractory Peripheral T-cell Lymphoma

Secura Bio, Inc. -, an integrated pharmaceutical company dedicated to the worldwide development and commercialization of impactful oncology therapies, announced that it completed enrollment on February 1, 2022, in the PRIMO study.

February 9, 2022

·

7 min read

Drug Development

Phoenix Molecular Designs Successfully Completes Patient Enrollment in Phase 1/1b Clinical Trial of PMD-026

Phoenix Molecular Designs, a clinical stage biopharmaceutical company dedicated to developing precise cancer therapeutics, announced the completion of patient enrollment and dosing of PMD-026 in their Phase 1b monotherapy clinical trial.

February 9, 2022

·

5 min read

BioMidwest

Biodesix to Present at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

Biodesix, Inc. announced Scott Hutton, Chief Executive Officer of Biodesix, will present in a fireside chat at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference being held virtually February 15-17, 2022.

February 9, 2022

·

3 min read

Business

Veru Reports First Quarter Fiscal 2022 Results as US FC2 Prescription Net Revenues Climb 27%

Veru Inc. today announced financial results for its fiscal 2022 first quarter ended December 31, 2021.

February 9, 2022

·

24 min read

Business

Foundation Medicine Announces Global Collaboration With Lilly to Develop FoundationOne®CDx and FoundationOne®Liquid CDx as Companion Diagnostics for RETEVMO® and Loxo Oncology at Lilly’s Pipeline Programs

Foundation Medicine, Inc. today announced a collaboration with Eli Lilly and Company (Lilly) for the development of Foundation Medicine’s tissue- and blood-based assays as companion diagnostics for RETEVMO.

February 9, 2022

·

5 min read

Genetown

Cogent Biosciences to Present at 11th Annual SVB Leerink Global Healthcare Conference

Cogent Biosciences, Inc. today announced Andrew Robbins, Chief Executive Officer and President, will participate in a fireside chat during the 11th Annual SVB Leerink Global Healthcare Conference, taking place virtually February 14 – 18, 2022.

February 9, 2022

·

1 min read